FEATURED COMPANIES
- BASF
- Covestro
- Green Fiber International
- Mitsui
- Reliance Industries
- Stein Fibers
Polymer Biomaterial Global Market Report 2021: COVID-19 Growth and Change to 2030 provides the strategists, marketers and senior management with the critical information they need to assess the global polymer biomaterial market.
This report focuses on the polymer biomaterial global market which is experiencing strong growth. The report gives a guide to the polymer biomaterial global market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.
Where is the largest and fastest growing market for polymer biomaterial? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Polymer Biomaterial market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider polymer biomaterial global market, and compares it with other markets.
BASF; Corbion; Zimmer Biomet; Royal DSM; Koninklijke DSM
Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Five years historic and ten years forecast.
Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Country and regional historic and forecast data, market share of competitors, market segments.
Data and analysis throughout the report is sourced using end notes.
This product will be delivered within 1-3 business days.
This report focuses on the polymer biomaterial global market which is experiencing strong growth. The report gives a guide to the polymer biomaterial global market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:
Where is the largest and fastest growing market for polymer biomaterial? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Polymer Biomaterial market global report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider polymer biomaterial global market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
- The polymer biomaterial market section of the report gives context. It compares the polymer biomaterial market with other segments of the polymer biomaterial market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, polymer biomaterial indicators comparison.
Scope
Markets Covered:
- By Type: Nylon; Silicone Rubber; Polyester; Polymethyl Methacrylate (PMMA); Polyethylene (PE); Polyvinyl Chloride; Others
- By Application: Cardiovascular; Ophthalmology; Dental; Plastic Surgery; Wound Healing; Tissue Engineering; Orthopedics; Neurological Disorders / Central Nervous System; Others
- By Nature: Natural; Synthetic
Companies Mentioned:
BASF; Corbion; Zimmer Biomet; Royal DSM; Koninklijke DSM
Countries:
Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions:
Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series:
Five years historic and ten years forecast.
Data:
Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data segmentations:
Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing:
Data and analysis throughout the report is sourced using end notes.
This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Polymer Biomaterial Market
What is the estimated value of the Global Polymer Biomaterial Market?
What is the growth rate of the Global Polymer Biomaterial Market?
What is the forecasted size of the Global Polymer Biomaterial Market?
Who are the key companies in the Global Polymer Biomaterial Market?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- BASF
- Covestro
- Green Fiber International
- Mitsui
- Reliance Industries
- Stein Fibers
1. Executive Summary2. Polymer Biomaterial Market Characteristics3. Polymer Biomaterial Market Trends and Strategies4. Impact Of COVID-19 On Polymer Biomaterial28. Key Mergers and Acquisitions in the Polymer Biomaterial Market29. Polymer Biomaterial Market Future Outlook and Potential Analysis
5. Polymer Biomaterial Market Size and Growth
6. Polymer Biomaterial Market Segmentation
7. Polymer Biomaterial Market Regional and Country Analysis
8. Asia-Pacific Polymer Biomaterial Market
9. China Polymer Biomaterial Market
10. India Polymer Biomaterial Market
11. Japan Polymer Biomaterial Market
12. Australia Polymer Biomaterial Market
13. Indonesia Polymer Biomaterial Market
14. South Korea Polymer Biomaterial Market
15. Western Europe Polymer Biomaterial Market
16. UK Polymer Biomaterial Market
17. Germany Polymer Biomaterial Market
18. France Polymer Biomaterial Market
19. Eastern Europe Polymer Biomaterial Market
20. Russia Polymer Biomaterial Market
21. North America Polymer Biomaterial Market
22. USA Polymer Biomaterial Market
23. South America Polymer Biomaterial Market
24. Brazil Polymer Biomaterial Market
25. Middle East Polymer Biomaterial Market
26. Africa Polymer Biomaterial Market
27. Polymer Biomaterial Market Competitive Landscape and Company Profiles
30. Appendix
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- BASF
- Covestro
- Green Fiber International
- Mitsui
- Reliance Industries
- Stein Fibers
Major players in the polymer biomaterial market are BASF, Corbion, Zimmer Biomet, Royal DSM, Koninklijke DSM, Covestro, Evonik Industries, Starch Medical, Victrex, and W. L. Gore & Associate.
The global polymer biomaterial market is expected to grow from $47.05 billion in 2020 to $53.87 billion in 2021 at a compound annual growth rate (CAGR) of 14.5%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $93.98 billion in 2025 at a CAGR of 15%.
The polymer biomaterial market consists of sales of polymer biomaterial and related services by entities (organizations, sole traders and partnerships) that produce polymer biomaterial used for enhancing the functionality of tissues and organs that are damaged in various disease therapies. Polymer biomaterials are inert pharmacological substances made up of natural and synthetic origin.
The polymer biomaterial market covered in this report is segmented by type into nylon, silicone rubber, polyester, polymethyl methacrylate (PMMA), polyethylene (PE), polyvinyl chloride, others and by application into cardiovascular, ophthalmology, dental, plastic surgery, wound healing, tissue engineering, orthopedics, neurological disorders/central nervous system, others.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Stringent regulatory systems concerning the biocompatibility of the polymer biomaterials is expected to limit the global polymer biomaterials market. Although biomaterials undergo rigorous premarket evaluations, considerable adverse events and complications are reported regarding the biocompatibility of polymer biomaterials. Biomaterial implantation may result in immunological and inflammatory reactions due to the induction of cellular and molecular events in the host, which may lead to excessive inflammation, impairment of healing, fibrotic encapsulation, tissue destruction, or even isolation and rejection of the implant. To overcome such adverse immune reactions, stringent regulations are imposed by the regulatory authorities, restricting market growth.
Companies in the polymer biomaterial market are increasingly investing in bioresorbable copolymers for medical devices for better performance and long-term stability. Companies such as Evonik have invested in bioresorbable polymers for use in implantable medical devices. The company's copolymer possesses hydrophobic properties of polylactide and hydrophilic properties of polyethylene glycol enabling the degradation rates up to six times faster with added mechanical strength. This innovation enhances biocompatibility, safety and performance of implantable products, and is applied in the areas of pediatrics and wound closure to accelerate and ease the healing process and provides long term stability.
In January 2020, Mitsubishi Chemical Corporation completed the acquisition of AdvanSource Biomaterials Corporation for $7.25 million. This acquisition is expected to strengthen Mitsubishi’s position within the medical sector and drive its revenues. AdvanSource Biomaterials is a US-based company that manufactures polymer materials that provide critical characteristics in the design and development of medical devices. These polymer biomaterials are used in devices that are designed for treating a broad range of anatomical sites and disease states.
Increasing applications of polymeric biomaterials in tissue engineering are driving the global polymer biomaterials market. Polymers are extensively used in regenerative medicine and tissue engineering due to their flexibility and versatile properties such as tailoring the damaged tissue's physical, chemical and mechanical properties by modification of functional groups during synthesis, according to the regeneration capability of tissues of the organs. Besides being biodegradable, they offer different geometry and structures, thus meeting the needs of specific tissue engineering applications. These growing applications of polymer biomaterial in tissue engineering are expected to drive the market in the forecast period.
The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
The global polymer biomaterial market is expected to grow from $47.05 billion in 2020 to $53.87 billion in 2021 at a compound annual growth rate (CAGR) of 14.5%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $93.98 billion in 2025 at a CAGR of 15%.
The polymer biomaterial market consists of sales of polymer biomaterial and related services by entities (organizations, sole traders and partnerships) that produce polymer biomaterial used for enhancing the functionality of tissues and organs that are damaged in various disease therapies. Polymer biomaterials are inert pharmacological substances made up of natural and synthetic origin.
The polymer biomaterial market covered in this report is segmented by type into nylon, silicone rubber, polyester, polymethyl methacrylate (PMMA), polyethylene (PE), polyvinyl chloride, others and by application into cardiovascular, ophthalmology, dental, plastic surgery, wound healing, tissue engineering, orthopedics, neurological disorders/central nervous system, others.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Stringent regulatory systems concerning the biocompatibility of the polymer biomaterials is expected to limit the global polymer biomaterials market. Although biomaterials undergo rigorous premarket evaluations, considerable adverse events and complications are reported regarding the biocompatibility of polymer biomaterials. Biomaterial implantation may result in immunological and inflammatory reactions due to the induction of cellular and molecular events in the host, which may lead to excessive inflammation, impairment of healing, fibrotic encapsulation, tissue destruction, or even isolation and rejection of the implant. To overcome such adverse immune reactions, stringent regulations are imposed by the regulatory authorities, restricting market growth.
Companies in the polymer biomaterial market are increasingly investing in bioresorbable copolymers for medical devices for better performance and long-term stability. Companies such as Evonik have invested in bioresorbable polymers for use in implantable medical devices. The company's copolymer possesses hydrophobic properties of polylactide and hydrophilic properties of polyethylene glycol enabling the degradation rates up to six times faster with added mechanical strength. This innovation enhances biocompatibility, safety and performance of implantable products, and is applied in the areas of pediatrics and wound closure to accelerate and ease the healing process and provides long term stability.
In January 2020, Mitsubishi Chemical Corporation completed the acquisition of AdvanSource Biomaterials Corporation for $7.25 million. This acquisition is expected to strengthen Mitsubishi’s position within the medical sector and drive its revenues. AdvanSource Biomaterials is a US-based company that manufactures polymer materials that provide critical characteristics in the design and development of medical devices. These polymer biomaterials are used in devices that are designed for treating a broad range of anatomical sites and disease states.
Increasing applications of polymeric biomaterials in tissue engineering are driving the global polymer biomaterials market. Polymers are extensively used in regenerative medicine and tissue engineering due to their flexibility and versatile properties such as tailoring the damaged tissue's physical, chemical and mechanical properties by modification of functional groups during synthesis, according to the regeneration capability of tissues of the organs. Besides being biodegradable, they offer different geometry and structures, thus meeting the needs of specific tissue engineering applications. These growing applications of polymer biomaterial in tissue engineering are expected to drive the market in the forecast period.
The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- BASF
- Corbion
- Zimmer Biomet
- Royal DSM
- Koninklijke DSM
- Covestro
- Evonik Industries
- Starch Medical
- Victrex
- W. L. Gore and Associate
- Bayer
- DSM Biomedical
- Purac Biomaterials
- Ticona
- Invibo
- Covalon Technologies
- Osteotech
- Medtronic
- Stryker Corporation
- Synthes
- Mitsui
- Polyfibre Industries
- Toray Industries
- Stein Fibers
- Diyou Fiber
- Silon
- Swicofil
- Green Fiber International
- Reliance Industries
Note: Product cover images may vary from those shown
LOADING...